Category: Clinical Trials

March 19, 2019

Medicine Clinical Trials Start-ups PhaseBio Reports Full Results from Phase 1 Clinical Trial

PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase...

MORE >
Eric Benner, Tellus Therapeutics speaking to people attending Invented at Duke, 2018

October 22, 2020

Duke Innovations Medicine Clinical Trials Start-ups Tellus Receives Orphan Drug/Rare Pediatric Disease Designations

With No Approved Treatments for Diffuse White Matter Injury in...

MORE >

April 17, 2019

Clinical Trials Start-ups Precision Announces Dosing of First Patient

Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to...

MORE >
Young female scientist holding liquid sample

July 12, 2019

Press Releases Clinical Trials Start-ups PhaseBio: Positive Results from Phase 2a Clinical Trial of PB2452

PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial...

MORE >

August 7, 2019

Clinical Trials Start-ups Polarean Enrols First Patient At University Of Cincinnati Trial Site

Polarean Imaging PLC on Monday announced enrolment of the first...

MORE >
TRND Pompe

February 2, 2018

Duke Innovations Press Releases Clinical Trials Pompe Gene Therapy Advances to Clinical Trials

[Orginially posted on National Center for Advancing Translational Sciences] NCATS Therapeutics for...

MORE >

August 14, 2019

Clinical Trials Start-ups PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on...

MORE >

September 18, 2019

Press Releases Clinical Trials Start-ups Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A

Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated...

MORE >

July 31, 2018

Clinical Trials Start-ups Polarean Imaging to start key clinical trials next month after pilot study success

[Originally posted by Trader News— July 27, 2018]   Medical...

MORE >